Multiple Myeloma

Filter By:
07:26
With many new and evolving myeloma treatments, how can patients ensure they are receiving the latest, state-of-the-ar​t care? Drs. John Burke and Robert Rifkin, Myeloma experts from US Oncology Research, explore important developments from the 2014 American Society of Hematology (ASH) meeting and explain how patients can work with their doctor to ac...
by:patientpower | 15 views
39:28
At the 2014 American Society of Hematology (ASH) meeting, Dr. Robert Orlowski from MD Anderson Cancer Center led a Patient Power roundtable discussion featuring Dr. Ola Landgren from Memorial Sloan Kettering Cancer Center, Dr. Edward Libby from Seattle Cancer Care Alliance and patient advocate and mentor Cynthia Chmielewski. The panel explored the ...
by:patientpower | 3 views
09:40
A leading myeloma expert, Dr. Noopur Raje, shares research highlights from the 2014 American Society of Hematology (ASH) meeting. Dr. Raje discusses developing approaches, including oral treatments, combination therapies and monoclonal antibodies. Get email alerts | http://www.p... Subscribe on YouTube | http://w...
by:patientpower | 55 views
03:15
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Keith Stewart (Mayo Clinic, Scottsdale, AZ) discusses recent advances in the treatment of multiple myeloma. The phase III ASPIRE study showed that adding the proteasome inhibitor, carfilzomib, to the standard doublet therapy of...
by:EMJ | 229 views
23:14
In this “Best of the Day” presentation from the 2014 Annual Hematology Meeting in San Francisco, Dr. Joseph R. Mikhael and Dr. Tomer M. Mark analyze and discuss the latest clinical data for the treatment and management of patients with multiple myeloma. This expert discussion and analysis provides updates for newly diagnosed, relapsed/refrac​tory di...
by:imedex | 104 views
23:32
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Catherine Bollard (Children's National Medical Center, Washington, DC), Dr Philippe Armand (Dana-Farber Cancer Institute, Boston, MA), Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY), Dr Nicola Gökbuget (Un...
by:EMJ | 128 views
06:35
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Keith Stewart from the Mayo Clinic in Arizona joined Patient Power to share unprecedented results of multiple myeloma research. Dr. Stewart spoke about the study using carfilzomib (Kyprolis®), a proteasome inhibitor, in combina...
by:patientpower | 161 views
06:18
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Thomas Martin from the UCSF Medical Center joined Patient Power to share encouraging multiple myeloma news coming out of the meeting. He discussed the latest results from a study combining a novel myeloma therapy with lenalidom...
by:patientpower | 121 views
19:05
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Brad Kahl (University of Wisconsin School of Medicine, Madison, WI), Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY), Dr Joseph Alvarnas (City of Hope National Medical Center, Duarte, CA), Prof Keith Stewar...
by:EMJ | 91 views
09:18
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Thomas Martin (University of California San Francisco, San Francisco, CA) discusses a phase Ib dose escalation trial of SAR650984 (anti-CD38 monoclonal antibody) in combination with lenalidomide and dexam...
by:EMJ | 128 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)